Leigh MacMillan

August 11, 2020

Risk marker for repeat sinus surgery

An inflammatory factor in mucus could be a biomarker of treatment-resistant chronic sinusitis used to determine which patients are at risk for repeat sinus surgery.

By Leigh MacMillan
August 6, 2020

ID of ‘stomach flu’ culprit

Identifying the norovirus genotypes associated with more severe infections in children could guide strain selection for candidate norovirus vaccines.

By Leigh MacMillan
August 6, 2020

Appendix cancer survival in young patients varies by race: study

The first study of appendiceal cancer patterns and survival by race/ethnicity among patients younger than 50 in the U.S. showed survival disparities.

By Leigh MacMillan
July 30, 2020

Hartmann named first Vice President for Research Integration

Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center.

By Leigh MacMillan
July 28, 2020

Post-transplant complication

Vanderbilt researchers conducted the largest analysis to date of a heart complication in children following stem cell transplant. The findings may help guide screening practices to improve outcomes.

By Leigh MacMillan
July 23, 2020

Stomach bug hit-and-run

The H. pylori machinery that “injects” an oncoprotein into stomach cells contributes to the development of gastric cancer, Vanderbilt researchers demonstrate.

By Leigh MacMillan
July 23, 2020

Kawai receives award to accelerate lupus research

Vivian Kawai, MD, MPH, research assistant professor of Medicine, has received an LRA-BMS Accelerator Award from the Lupus Research Alliance and sponsoring partner Bristol Myers Squibb.
By Leigh MacMillan
July 23, 2020

Cellular antiviral defenses

A cellular RNA quality control mechanism was known to restrict replication of RNA viruses. Vanderbilt researchers have discovered it is also antiviral against DNA viruses.
By Leigh MacMillan
July 14, 2020

VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.
By Leigh MacMillan
July 14, 2020

New tools to study bioactive lipids

Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction.
By Leigh MacMillan
July 9, 2020

VUMC’s Byndloss recognized for microbiome research

Mariana Byndloss, DVM, PhD, assistant professor of Pathology, Microbiology and Immunology, has been selected as a runner-up of the inaugural NOSTER & Science Microbiome Prize.
By Leigh MacMillan
July 9, 2020

New space bolsters infectious disease and immunology discovery

The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home.
By Leigh MacMillan
1 … 22 23 24 25 26 … 79